Skip to main content
Log in

The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Robinson WH, Genovese MC, Moreland LW. Demyelinating and neurologic events reported in association with tumor necrosis factor a antagonism: by what mechanisms could tumor necrosis factor α antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 2001; 44: 1977–83.

    Article  CAS  PubMed  Google Scholar 

  2. Cope AP, Liblau RS, Yang XD, et al. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med 1997; 185: 1573–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Cope A, Ettinger R, McDevitt H. The role of TNF α and related cytokines in the development and function of the autoreactive T-cell repertoire. Res Immunol 1997; 148: 307–12.

    Article  CAS  PubMed  Google Scholar 

  4. Stübgen JP. Tumor necrosis factor-α antagonists and neuropathy. Muscle Nerve 2008; 37: 281–92.

    Article  PubMed  Google Scholar 

  5. Lozeron P, Denier C, Lacroix C, Adams D. Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-α- blocker therapy. Arch Neurol 2009; 66: 490–7.

    Article  PubMed  Google Scholar 

  6. Dalakas MC, Medscape MC. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol 2011; 7: 507–17.

    Article  PubMed  Google Scholar 

  7. Yan WX, Taylor J, Andrias-Kauba S, Pollard JD. Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients. Ann Neurol 2000; 47: 765–75.

    Article  CAS  PubMed  Google Scholar 

  8. Dalakas MC, Engel WK. Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy. Arch Neurol 1980; 37: 637–40.

    Article  CAS  PubMed  Google Scholar 

  9. Bachmann R, Eugster HP, Frei K, Fontana A, Lassmann H. Impairment of TNF-receptor-1 signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice. Am J Pathol 1999; 154: 1417–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Mahil SK, Andrews TC, Brierley C, Barker JN, Smith CH. Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature. J Dermatolog Treat 2013; 24: 38–49.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshihide Asano.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakao, M., Asano, Y., Nakamura, K. et al. The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris. Eur J Dermatol 26, 404–405 (2016). https://doi.org/10.1684/ejd.2016.2781

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2016.2781

Navigation